More Post from the Author
- Keys Inc. Marks a Strong First Half of 2025 with New Features and Industry Growth
- ITRI Advances Taiwan's 6G Global Partnerships in the EU and the UK
- Global Times: 'Our pursuit of modern economic development must be underpinned by strategic foresight and holistic coordination'
- Yingfa Ruineng, Srdrlebilirlik Yoluyla Fotovoltaik Sektrne Liderlik Etmeyi Hedefleyerek BM Kresel lkeler Szlemesine Katld
- BUTLER NATIONAL CORPORATION ANNOUNCES FISCAL YEAR END 2025 FINANCIAL RESULTS
QuantalX Neuroscience Announces CE MDR Approval, Making Brain Health Assessment Available in the EU
Published on Wed 12 Feb 2025 8:06:42 UTC

The company announces CE MDR approval for its novel Delphi-MD neurodiagnosis medical device in preparation for EU commercialization, improving patients' clinical outcomes and well being while reducing healthcare systems and payors' financial burden.
NEW YORK, Feb. 12, 2025 /PRNewswire/ --QuantalX Neuroscience Ltd. is proud to announce that its groundbreaking brain health assessment device, the Delphi-MD, has received CE MDR approval, the European Union's certification under the new Medical Device Regulation (MDR). The CE MDR certification process sets a new benchmark for safety, efficacy, and quality in medical devices. This achievement underscores QuantalX's commitment to innovation and excellence in neurological care.
More Post from the Author
- Keys Inc. Marks a Strong First Half of 2025 with New Features and Industry Growth
- ITRI Advances Taiwan's 6G Global Partnerships in the EU and the UK
- Global Times: 'Our pursuit of modern economic development must be underpinned by strategic foresight and holistic coordination'
- Yingfa Ruineng, Srdrlebilirlik Yoluyla Fotovoltaik Sektrne Liderlik Etmeyi Hedefleyerek BM Kresel lkeler Szlemesine Katld
- BUTLER NATIONAL CORPORATION ANNOUNCES FISCAL YEAR END 2025 FINANCIAL RESULTS